Jamie Atkins


Jamie is an Associate in our Life Sciences and Chemistry group and his practice focuses on biopharmaceuticals, diagnostics and synthetic biology, with expertise in immunotherapy, CRISPR and RNAi. 
He has significant experience in due diligence and freedom to operate exercises in a variety of technical areas, including antibodies and biomarkers. A particular strength is designing and advising on freedom to operate strategies to suit a range of budgets and commercial requirements.
In addition to handling the drafting and prosecution of patent applications and the filing of registered design applications, Jamie has been involved in some of the most commercially important and legally complex oppositions in the life sciences field at the European Patent Office (EPO).

He lectures on intellectual property at University College London for biochemical engineers and is a regular contributor to Intellectual Property Magazine, providing commentary and insights on CRISPR patent news.
Jamie graduated from the University of Bristol with a first class degree in biochemistry, which included modules in pharmacology, chemistry and the molecular basis of diseases.


Jamie was recognised as a 'Rising Star' in Managing IP Stars 2019


European Patent Attorney
Chartered UK Patent Attorney
IP Litigator - Patent
Certificate in Intellectual Property Law - Queen Mary College, University of London
BSc Biochemistry - University of Bristol



Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)

Selected Publications

Broad Institute wins CRISPR Appeal, Kilburn & Strode Publication (September 2018)
CRISPR patent KO shows the importance of getting your priorities right, Intellectual Property Magazine (February 2018)
Dividing the spoils - CRISPR technology is revolutionising genetic research but could the patent war hinder its progress? Intellectual Property Magazine (August 2017).
Supreme Court to weigh in on major second medical use patent case, Kilburn & Strode Publication (March 2017)
Victory for Broad in CRISPR interference proceedings, Intellectual Property Magazine (March 2017)
Patents Court grants new form of declaration aimed at providing commercial certainty, Kilburn & Strode Publication (March 2017)
Battle for CRISPR patents heats up, Intellectual Property Magazine (February 2017)

J. Atkins, Broad Institute wins CRISPR Appeal, Kilburn & Strode, (2019)

J. Atkins, Prioritising the Priority Claim, Kilburn & Strode, (2019)

  • Biotechnology
  • Medical Devices
  • Biologics
  • Healthcare
  • Patents

The life sciences and chemistry team regularly writes about trends, developments and legal updates in the IP industry in our News & insights hub.

Read here

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept